Cadila Healthcare

India to initially introduce ZyCoV-D Covid-19 vaccine in seven states including Tamil Nadu

The health ministry has reportedly placed a purchase order for one crore dozes of Zydus Cadila's three-dose Covid-19 vaccine.

published on : 2nd December 2021

Four more Covid vaccine candidates in human trial stage, one in pre-clinical stage: Government

Union Minister Jitendra Singh said Cadila Healthcare Ltd's DNA-based vaccine candidate is in phase three clinical trial and it has submitted the interim data for emergency use authorisation.

published on : 21st July 2021

Zydus Cadila seeks DCGI nod for human clinical trials of antibodies cocktail to treat COVID-19

Cadila Healthcare is the listed entity of the group. ZRC-3308 has been found to be safe and well tolerated in animal toxicology studies.

published on : 27th May 2021